325440
CEOs of rural healthcare facilities offer insight into telehealth adoption opportunities
Method: Using random stratified sampling, researchers completed 24 key informant semi-structured interviews based on short-answer and open-ended questions. Interviews were coded using Nvivo qualitative analysis software.
Results: Preliminary analysis indicates facilities were at various stages along the diffusion of innovation model. Twelve facilities were using telehealth, five were exploring, and six were not considering telehealth. Recruitment and retention of staff were key operational barriers identified (11/24). Interviews also illuminated a distinct tension between giving providers a decision-making role in technology adoption and recognition of providers’ own fears of being replaced by technology. Other barriers such as patient acceptance were identified.
Conclusions: Rural healthcare facility CEOs recognize the need for support from providers. Interviews suggest ways telehealth not only benefits patients but providers as well. These may be critical provider recruitment and retention tools for rural healthcare facilities. Additionally, groups seeking to advance telehealth can educate providers and CEOs on the technology’s multiple uses and benefits.
Learning Areas:
Administration, management, leadershipCommunication and informatics
Provision of health care to the public
Learning Objectives:
Describe two operational challenges for rural healthcare administrators that can be mitigated by telehealth.
Identify three barriers to telehealth adoption and discuss potential solutions.
Define two key strategies for increasing internal buy-in for telehealth.
Keyword(s): Telehealth, Marketing
Qualified on the content I am responsible for because: I have three years experience in health communication research and have been a researcher for several federally funded grants related to health communication and public health.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.